biology: Dr Reddy’s Laboratories jumps into the fray for Biogen’s biosimilarsby India News Online Team September 16, 2023 0 Dr Reddy's Laboratories (DRL) has joined the race to acquire the biosimilar products portfolio of US-based Biogen in a transaction worth a potential $1 billion, according to two people ...